eCite Digital Repository

Review article: Luminex technology for HLA antibody detection in organ transplantation


Tait, BD and Hudson, F and Cantwell, L and Brewin, G and Holdsworth, R and Bennett, G and Jose, M, Review article: Luminex technology for HLA antibody detection in organ transplantation, Nephrology, 14, (2) pp. 247-254. ISSN 1320-5358 (2009) [Refereed Article]

Copyright Statement

Copyright 2009 The Authors Journal compilation copyright 2009 Asian Pacific Society of Nephrology

DOI: doi:10.1111/j.1440-1797.2008.01074.x


Since its inception in the early 1960s, the serologically based complement-dependent cytotoxicity(CDC) assay has been the cornerstone technique for the detection of human leucocyte antigen (HLA) antibodies,not only in pre-transplant renal patients, but also in other forms of organ transplantation. Recently, solid phase assays have been developed and introduced for this purpose, and in particular the Flow-based bead assays such as the Luminex system. This latter assay has proved to be far more sensitive than the CDC assay and has revealed pre-sensitization in potential transplant recipients not detected by other methods of HLA antibody detection. However, the clinical implications of this increased sensitivity have not been convincingly demonstrated until recently. This technology for HLA antibody detection permits the evaluation of the clinical importance of antibodies directed at, for example, HLA-DPB1 and HLA-DQA1, which has not been possible to date. There are Luminex issues, however, requiring resolution such as the ability to distinguish between complement fixing and non-complement fixing antibodies and determination of their relative clinical significance. Luminex technology will permit a re-evaluation of the role of HLA antibodies in both early and late antibody-mediated rejection.

Item Details

Item Type:Refereed Article
Keywords:anti-HLA antibodies, rejection, renal, solid phase assays
Research Division:Biomedical and Clinical Sciences
Research Group:Immunology
Research Field:Transplantation immunology
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Jose, M (Professor Matthew Jose)
ID Code:60227
Year Published:2009
Web of Science® Times Cited:107
Deposited By:Menzies Institute for Medical Research
Deposited On:2010-01-25
Last Modified:2014-05-20

Repository Staff Only: item control page